Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like A new link between brain health and mitochondrial function December 19, 2024 Optimizing influenza vaccine strategies with nanoparticle immunization July 11, 2024 Once-Weekly Insulins For Type 1 Diabetes: Latest Research Update October 17, 2023